Why the study?
Does higher adherence to antihypertensive medication reduce healthcare use and Medicaid expenditures for acute cardiovascular events?
Does higher adherence to antihypertensive medication reduce healthcare use and Medicaid expenditures for acute cardiovascular events?
Higher adherence to antihypertensive medications offsets increased medication costs through reduced Medicaid spending on acute cardiovascular events.
May support adherence programs to offset Medicaid costs; leaves open causal benefits pending randomized trials.
Lower adherence to AHM was associated with progressively higher CVD risk. The increase in medication cost from higher AHM adherence was offset solely by reduced Medicaid spending on acute CVD events.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2016) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: